{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:23:40Z","timestamp":1768076620030,"version":"3.49.0"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:p>We report a case of neonatal Graves' disease involving an infant with severe persistent pulmonary hypertension (PPHN) associated with neonatal thyrotoxicosis that necessitated extracorporeal membrane oxygenation. Hyperthyroidism, although uncommon in the newborn period, has been associated with pulmonary hypertension among adults. The exact mechanisms responsible for this effect on pulmonary vascular pressure are not well understood. Recent studies have provided evidence that thyrotoxicosis has direct and indirect effects on pulmonary vascular maturation, metabolism of endogenous pulmonary vasodilators, oxygen economy, vascular smooth muscle reactivity, and surfactant production, all of which may contribute to the pathophysiologic development of PPHN. Therefore, because PPHN is a significant clinical entity among term newborns and the symptoms of hyperthyroidism may be confused initially with those of other underlying disorders associated with PPHN (eg, sepsis), it would be prudent to perform screening for hyperthyroidism among affected newborns.<\/jats:p>","DOI":"10.1542\/peds.2004-0554","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T18:31:21Z","timestamp":1485455481000},"page":"e105-e108","source":"Crossref","is-referenced-by-count":26,"title":["Neonatal Thyrotoxicosis and Persistent Pulmonary Hypertension Necessitating Extracorporeal Life Support"],"prefix":"10.1542","volume":"115","author":[{"given":"Jon","family":"Oden","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology and Diabetes"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira M.","family":"Cheifetz","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care Medicine, Duke Children's Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,1,1]]},"reference":[{"key":"2021121011043839300_R1","doi-asserted-by":"crossref","unstructured":"Marvisi M, Brianti M, Marani G, Del Borello P, Bortesi ML, Guariglia A. Hyperthyroidism and pulmonary hypertension. Respir Med.\u20082002;96:215\u2013220","DOI":"10.1053\/rmed.2001.1260"},{"key":"2021121011043839300_R2","doi-asserted-by":"crossref","unstructured":"Nakchbandi IA, Wirth JA, Inzucchi SE. Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by 131I treatment. Chest.\u20081999;116:1483\u20131485","DOI":"10.1378\/chest.116.5.1483"},{"key":"2021121011043839300_R3","doi-asserted-by":"crossref","unstructured":"Gross I. Recent advances in respiratory care of the term neonate. Ann NY Acad Sci.\u20082000;900:151\u2013158","DOI":"10.1111\/j.1749-6632.2000.tb06225.x"},{"key":"2021121011043839300_R4","doi-asserted-by":"crossref","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med.\u20082001;344:501\u2013509","DOI":"10.1056\/NEJM200102153440707"},{"key":"2021121011043839300_R5","doi-asserted-by":"crossref","unstructured":"Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid.\u20081999;9:727\u2013733","DOI":"10.1089\/thy.1999.9.727"},{"key":"2021121011043839300_R6","doi-asserted-by":"crossref","unstructured":"Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev.\u20081997;18:404\u2013433","DOI":"10.1210\/edrv.18.3.0300"},{"key":"2021121011043839300_R7","doi-asserted-by":"crossref","unstructured":"Archavachotikul K, Ciccone TJ, Chinoy MR, Nielsen HC, Volpe MV. Thyroid hormone affects embryonic mouse lung branching morphogenesis and cellular differentiation. Am J Physiol Lung Cell Mol Physiol.\u20082002;282:L359\u2013L369","DOI":"10.1152\/ajplung.00400.2000"},{"key":"2021121011043839300_R8","doi-asserted-by":"crossref","unstructured":"Massaro D, Massaro GD. Pulmonary alveoli: formation, the \u201ccall for oxygen,\u201d and other regulators. Am J Physiol Lung Cell Mol Physiol.\u20082002;282:L345\u2013L358","DOI":"10.1152\/ajplung.00374.2001"},{"key":"2021121011043839300_R9","doi-asserted-by":"crossref","unstructured":"Smith DM, Hitchcock KR. Thyroid hormone binding to adult rat alveolar type II cells: an autoradiographic study. Exp Lung Res.\u20081983;5:141\u2013153","DOI":"10.3109\/01902148309061510"},{"key":"2021121011043839300_R10","doi-asserted-by":"crossref","unstructured":"Keijzer R, van Tuyl M, Tibboel D. Hormonal modulation of fetal pulmonary development: relevance for the fetus with diaphragmatic hernia. Eur J Obstet Gynecol Reprod Biol.\u20082000;92:127\u2013133","DOI":"10.1016\/S0301-2115(00)00436-X"},{"key":"2021121011043839300_R11","doi-asserted-by":"crossref","unstructured":"Morishige WK, Joun NS. Influence of glucocorticoids on postnatal lung development in the rat: possible modulation by thyroid hormone. Endocrinology.\u20081982;111:1587\u20131594","DOI":"10.1210\/endo-111-5-1587"},{"key":"2021121011043839300_R12","doi-asserted-by":"crossref","unstructured":"Zhou H, Morotti RA, Profitt SA, et al. Expression of thyroid transcription factor-1, surfactant proteins, type 1 cell-associated antigen, and Clara cell secretory protein in pulmonary hypoplasia. Pediatr Dev Pathol.\u20082001;4:364\u2013371","DOI":"10.1007\/s10024001-0002-9"},{"key":"2021121011043839300_R13","doi-asserted-by":"crossref","unstructured":"Losada A, Tovar JA, Xia HM, Diez-Pardo JA, Santisteban P. Down-regulation of thyroid transcription factor-1 gene expression in fetal lung hypoplasia is restored by glucocorticoids. Endocrinology.\u20082000;141:2166\u20132173","DOI":"10.1210\/endo.141.6.7522"},{"key":"2021121011043839300_R14","doi-asserted-by":"crossref","unstructured":"Yasuda T, Ohnishi H, Wataki K, Minagawa M, Minamitani K, Niimi H. Outcome of a baby born from a mother with acquired juvenile hypothyroidism having undetectable thyroid hormone concentrations. J Clin Endocrinol Metab.\u20081999;84:2630\u20132632","DOI":"10.1210\/jc.84.8.2630"},{"key":"2021121011043839300_R15","doi-asserted-by":"crossref","unstructured":"Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial: thyroid hormone replacement in neonates. Pediatr Res.\u20082003;53:48\u201356","DOI":"10.1203\/00006450-200301000-00011"},{"key":"2021121011043839300_R16","doi-asserted-by":"crossref","unstructured":"Hampl V, Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev.\u20082000;80:1337\u20131372","DOI":"10.1152\/physrev.2000.80.4.1337"},{"key":"2021121011043839300_R17","doi-asserted-by":"crossref","unstructured":"Hermenegildo C, Medina P, Peiro M, et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. J Clin Endocrinol Metab.\u20082002;87:5636\u20135640","DOI":"10.1210\/jc.2002-020905"},{"key":"2021121011043839300_R18","unstructured":"West JB. Respiratory Physiology: The Essentials. 4th ed. Baltimore, MD: Williams & Wilkins; 1990"},{"key":"2021121011043839300_R19","doi-asserted-by":"crossref","unstructured":"Hagiwara M, Mamiya S, Ochiai M, Hidaka H. Thyroid hormones inhibit the Ca2+ calmodulin-induced activation of myosin light chain kinase. Biochem Biophys Res Commun.\u20081988;152:270\u2013276","DOI":"10.1016\/S0006-291X(88)80710-1"},{"key":"2021121011043839300_R20","doi-asserted-by":"crossref","unstructured":"Nabishah BM, Morat PB, Alias AK, Kadir BA, Khalid BA. Cyclic adenosine 3\u2032,5\u2032-monophosphate content and bronchial smooth muscle contractility of hyper- and hypothyroid lungs. Clin Exp Pharmacol Physiol.\u20081992;19:839\u2013842","DOI":"10.1111\/j.1440-1681.1992.tb00423.x"},{"key":"2021121011043839300_R21","doi-asserted-by":"crossref","unstructured":"Klein I, Ojamaa K. Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res.\u20082001;88:260\u2013261","DOI":"10.1161\/01.RES.88.3.260"},{"key":"2021121011043839300_R22","doi-asserted-by":"crossref","unstructured":"Napoli R, Biondi B, Guardasole V, et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation.\u20082001;104:3076\u20133080","DOI":"10.1161\/hc5001.100621"},{"key":"2021121011043839300_R23","doi-asserted-by":"crossref","unstructured":"Gonzales LW, Ballard PL, Ertsey R, Williams MC. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab.\u20081986;62:678\u2013691","DOI":"10.1210\/jcem-62-4-678"},{"key":"2021121011043839300_R24","doi-asserted-by":"crossref","unstructured":"Clements JA, Avery ME. Lung surfactant and neonatal respiratory distress syndrome. Am J Respir Crit Care Med.\u20081998;157:S59\u2013S66","DOI":"10.1164\/ajrccm.157.4.nhlb1-1"},{"key":"2021121011043839300_R25","doi-asserted-by":"crossref","unstructured":"Gross I, Dynia DW, Wilson CM, Ingleson LD, Gewolb IH, Rooney SA. Glucocorticoid-thyroid hormone interactions in fetal rat lung. Pediatr Res.\u20081984;18:191\u2013196","DOI":"10.1203\/00006450-198402000-00017"},{"key":"2021121011043839300_R26","unstructured":"Senturk T, Kozaci LD, Kok F, Kadikoylu G, Bolaman Z. Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med.\u20082003;26:58\u201363"},{"key":"2021121011043839300_R27","doi-asserted-by":"crossref","unstructured":"Salvi M, Pedrazzoni M, Girasole G, et al. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol.\u20082000;143:197\u2013202","DOI":"10.1530\/eje.0.1430197"},{"key":"2021121011043839300_R28","doi-asserted-by":"crossref","unstructured":"Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JAH, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab.\u20082000;85:1984\u20131988","DOI":"10.1210\/jcem.85.5.6588"},{"key":"2021121011043839300_R29","doi-asserted-by":"crossref","unstructured":"Suzuki K, Lavaroni S, Mori A. Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci USA.\u20081998;95:8251\u20138256","DOI":"10.1073\/pnas.95.14.8251"},{"key":"2021121011043839300_R30","doi-asserted-by":"crossref","unstructured":"Bingle CD. Thyroid transcription factor-1. Int J Biochem Cell Biol.\u20081997;29:1471\u20131473","DOI":"10.1016\/S1357-2725(97)00007-1"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/1\/e105\/1003641\/zpe0010500e105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/1\/e105\/1003641\/zpe0010500e105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:04:16Z","timestamp":1639181056000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/1\/e105\/66942\/Neonatal-Thyrotoxicosis-and-Persistent-Pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1,1]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-0554","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}